Concepedia

Author

R Stoltz

Covance (United States)

Also Known As

A Dahlberg, Cal Francisco, D San, Francisco San, Minnesota Sutton, Ohio Stoltz, P Elliker, R Becker, R R Stoltz, R Stoltz

58

Publications

1.5K

Citations

20

H-Index

48

Concepts

All Affiliations

Covance (United States)Eli Lilly (United States)Actelion (Switzerland)Merck & Co., Inc., Rahway, NJ, USA (United States)Karolinska Institutet
RS

About

R Stoltz is an author at Covance (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

858

2

Health Sciences

4

4

259

3

Allergy

1

1

325

4

Allergy Medicine

1

1

325

5

Diabetes

1

1

46

R Stoltz

×

22

Publications

1.5K

Citations

20

H-Index

YearCitations

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★

Thomas B. Casale, William W. Busse, Craig LaForce,

Journal of Allergy and Clinical Immunology

1997

325

Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine

Goldstein Dj, O Wang, JR Saper,

Cephalalgia

1997

221

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

HR Black, Alan Graff, D Shute,

Journal of Human Hypertension

1997

120

Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects

Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher,

The Journal of Clinical Pharmacology

2014

90

Effects of Age, Gender, and Race/Ethnicity on the Pharmacokinetics of Posaconazole in Healthy Volunteers

Angela Sansone‐Parsons, Gopal Krishna, Jason S. Simon,

Antimicrobial Agents and Chemotherapy

2006

86

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

Matt S. Anderson, Thomas N. Kakuda, William D. Hanley,

Antimicrobial Agents and Chemotherapy

2008

79

CK‐2127107 amplifies skeletal muscle response to nerve activation in humans

Jinsy Andrews, Vipin Vijayakumar, R Stoltz,

Muscle & Nerve

2017

66

Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib

Yan Jin, C. Smith, Lei Hu,

Clinical Pharmacology & Therapeutics

2015

62

A randomized crossover study to evaluate Ro 115–1240, a selective α <sub>1A/1L</sub> ‐adrenoceptor partial agonist in women with stress urinary incontinence

D.M. Musselman, Anthony Ford, Daniel Gennevois,

British Journal of Urology

2003

53

Multiple‐Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double‐Blind Study

Elizabeth K. Hussey, Robert L. Dobbins, R Stoltz,

The Journal of Clinical Pharmacology

2010

46

Page 1